For a long time, we have been planning an episode of the EMCases Journal Jam series that will look at the evidence for or against TXA in almost all clinical settings. (It has been in the planning stages for a long time, because it is un-surprisingly hard to coordinate the […]
It doesn’t seem possible, but First10EM has now been part of my life for 5 years. The first post went up on March 4th 2015 (and seems a little dated now, but I think the ethos of being mentally prepared for the first 10 minutes of the worst emergencies still […]
Double sequential defibrillation has been all the rage over the last few years in emergency medicine. If one shock isn’t enough, use two. (By that logic, I am sort of surprised that no one has moved on to triple sequential defibrillation yet, but there is still time.) There has never […]
A new paper was published this month that is likely to change the way that a lot of people manage spontaneous pneumothorax (although I don’t think it will significantly change my practice)…
In the Rapid Review series, I briefly review the key points of a clinical review paper. (Well, this time it is a combination of 3 papers. The topic: Shiitake dermatitis
Everyone knows about the CRASH-2 trial. It is now a decade old. It doesn’t seem like it desperately needs a new blog post, but I think that understanding this trial is important when trying to interpret the results of the newer CRASH-3 or WOMAN trials, and other TXA research that […]
Sucrose is not a pain medication. That rant already exists on this blog. It was also the subject of my talk at the final SMACC conference, which is now online. Another blog post is probably unnecessary, but neither resource included the references from my literature review, so for those who […]
Tamiflu doesn’t work – at least not for anything important. In fact, because of its many side effects, it is probably harmful. For anyone following this evidence based debacle over the last decade, I think that conclusion is pretty clear. You can read a little bit about the Tamiflu saga […]
Since my rather lengthy write up of the stroke literature, there have been new RCTs published looking at thrombolytics for acute ischemic stroke. No, we haven’t got the replication of NINDS that we so desperately need. However, the new trials do represent a step forward in our thinking about stroke: […]